Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas

PLoS One. 2013 Nov 25;8(11):e79990. doi: 10.1371/journal.pone.0079990. eCollection 2013.

Abstract

Hereditary Hemochromatosis (HH) is a recessively inherited disorder of iron overload occurring commonly in subjects homozygous for the C282Y mutation in HFE gene localized on chromosome 6p21.3 in linkage disequilibrium with the human leukocyte antigen (HLA)-A locus. Although its genetic homogeneity, the phenotypic expression is variable suggesting the presence of modifying factors. One such genetic factor, a SNP microhaplotype named A-A-T, was recently found to be associated with a more severe phenotype and also with low CD8(+)T-lymphocyte numbers. The present study aimed to test whether the predictive value of the A-A-T microhaplotype remained in other population settings. In this study of 304 HH patients from 3 geographically distant populations (Porto, Portugal 65; Alabama, USA 57; Nord-Trøndelag, Norway 182), the extended haplotypes involving A-A-T were studied in 608 chromosomes and the CD8(+) T-lymphocyte numbers were determined in all subjects. Patients from Porto had a more severe phenotype than those from other settings. Patients with A-A-T seemed on average to have greater iron stores (p = 0.021), but significant differences were not confirmed in the 3 separate populations. Low CD8(+) T-lymphocytes were associated with HLA-A*03-A-A-T in Porto and Alabama patients but not in the greater series from Nord-Trøndelag. Although A-A-T may signal a more severe iron phenotype, this study was unable to prove such an association in all population settings, precluding its use as a universal predictive marker of iron overload in HH. Interestingly, the association between A-A-T and CD8(+) T-lymphocytes, which was confirmed in Porto and Alabama patients, was not observed in Nord-Trøndelag patients, showing that common HLA haplotypes like A*01-B*08 or A*03-B*07 segregating with HFE/C282Y in the three populations may carry different messages. These findings further strengthen the relevance of HH as a good disease model to search for novel candidate loci associated with the genetic transmission of CD8(+) T-lymphocyte numbers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alabama
  • CD8-Positive T-Lymphocytes / metabolism*
  • Female
  • Ferritins / blood
  • Genetic Association Studies
  • Genetic Markers
  • Geography
  • Haplotypes*
  • Hemochromatosis / genetics*
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I / genetics*
  • Humans
  • Iron / metabolism*
  • Major Histocompatibility Complex / genetics*
  • Male
  • Membrane Proteins / genetics*
  • Norway
  • Polymorphism, Single Nucleotide
  • Portugal

Substances

  • Genetic Markers
  • HFE protein, human
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I
  • Membrane Proteins
  • Ferritins
  • Iron

Grants and funding

FEDER through the program POFC-COMPETE (COMPETE “FCOMP-01-0124-FEDER-008447”) and portuguese national funds through the FCT (Portuguese Foundation for Science and Technology) grants: PTDC/SAU-GMC/67868/2006, PIC/IC/82785/2007and SFRH/BD/69186/2010; and partly by: 2) INOVA/APRF, USA; 3)The BIIC-Programa Roche/ICBAS/HAS 2008/2010; 4)Southern Iron Disorders Center, Birmingham, Alabama; 5) Nord-Trøndelag Health Study (The HUNT Study), a collaboration between HUNT Research Centre (Faculty of Medicine, Norwegian University of Science and Technology NTNU), Nord-Trøndelag County Council and The Norwegian Institute of Public Health; 6) The Cancer Foundation at St. Olav Hospital, Trondheim; 7) The Throne Holst Foundation, Oslo; 8) The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) and 9) The Norwegian Haemochromatosis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.